Good morning to you all. Please find enclosed a summary of the breaking small-cap and micro-cap financial news we highlighted on AGORACOM Small Cap TV this morning. It’s Aug 14th, 2012, and we’ve found 9 great press releases to report on at the open. Another great day for small-cap and micro-cap financial news. To watch the show live every morning at 9:30 AM, visit our front page ... or click on the image below.

Pretium Resources Inc.: 3,874 Grams Per Tonne Gold Intersection Extends Valley of the Kings West of the Brucejack Fault

Pretium Resources Inc. (TSX:PVG)(NYSE:PVG)

is pleased to report that step-out drilling has extended the zone of high-grade gold mineralization in the Valley of the Kings to the west of the Brucejack Fault by over 60 meters.

The bonanza-grade intercept from a downhole depth of 75.62 meters in hole SU-498 includes:

• 0.5 meters grading 3,874 grams of gold per tonne uncut (1.6 feet averaging 112.9 ounces gold per ton).

About Pretivm

Pretivm is creating value through gold at its advanced-staged exploration projects Brucejack and Snowfield, located in northern British Columbia. Pretivm is advancing the high-grade, underground gold opportunity at Brucejack, which hosts a significant undeveloped high-grade gold resource.

Last: 14.80Range: 18.15-8.27Market Cap: 1.3 billion

Link to hub

Timmins Gold Reports Profit From Operations of $13.6 Million for Q2 2012

Timmins Gold Corp. (TSX:TMM)(NYSE MKT:TGD)(NYSE Amex:TGD) (the "Company") is pleased to report its second quarter of 2012 financial results for the period ended June 30, 2012. For comparative purposes, Q2 2011 below refers to the three months ended June 30, 2011. All results are presented in United States dollars ("US Dollars") unless otherwise stated. Readers should refer to the Q2 2012 management discussion and analysis and condensed interim consolidated financial statements for complete information.

Q2 2012 HIGHLIGHTS

--Metal revenues were $38.2 million, compared to $27.0 million during the same 
prior year period. This represents a 41% increase over the prior year. 

--Profit from operations was $13.6 million, compared to $10.4 million

during the same prior year period. This represents a 31% increase over the prior year. 

--Cash flows from operations were $7.5 million, compared to $6.0 millionduring the same prior year period. After excluding changes in non-cash working capital items, finance expense paid, and income tax paid the cash flows were $17.5 million, compared to $15.5 million during the same prior year period. 

About Timmins Gold

Focused solely in Mexico, Timmins Gold Corp. is in commercial gold production at its wholly owned San Francisco gold mine in Sonora, Mexico. The mine is an open pit heap leach operation. Timmins Gold has forecast production at a rate in excess of 100,000 ounces of gold per year. (Micon International NI 43-101F1 Technical Report dated November, 2011).

Last: 2.12Range: 3.45-1.49Market Cap: 303 million

Link to hub 

Silver Bull Intersects 309g/t Silver Over 23 Meters Including 1,648g/t Silver Over 4 Meters on the Sierra Mojada Project, Coahuila, Mexico

Silver Bull Resources, Inc. (TSX:SVB)(NYSE MKT:SVBL)(NYSE Amex:SVBL)

is pleased to announce the drill results for the first 6 holes of the underground drill program (see June 12, 2012 news release) twinning a series of holes in a high grade zone defined by a historical "long hole" data set at the eastern end of the Shallow Silver Zone on the Sierra Mojada Project in Coahuila, Northern Mexico.

Highlights from the first 6 holes include:

--High grade silver intercepts including: 23 meters @ 309g/t Ag (including

4m @ 1,648g/t Ag), 21 meters @ 242g/t Ag (including 3.5m @ 916g/t Ag),

19.9 meters @ 192g/t Ag (including 4.05m @ 524g/t Ag), and 5 meters @

152g/t Ag. 

--High grade zinc intercepts including: 19.2 meters @ 10.42% Zn, 12.75

meters @ 7.52% Zn, 13 meters @ 3.83% Zn, and 14.90 meters @ 2.02% Zn. 

-- Mineralization remains open in the north, south, east and westerly

directions.

About Silver Bull: Silver Bull is a US registered mineral exploration company 
listed on both the NYSE MKT and TSX stock exchanges and based out of 
Vancouver, Canada. The flag ship "Sierra Mojada" project is located 150 
kilometers north of the city of Torreon in Coahuila, Mexico, and is highly 
prospective for silver and zinc. Silver Bull also has 2 mineral licences in 
Gabon, Central Africa, which are prospective for gold, manganese, and iron ore.

Last: 0.465Range: 0.75-0.41Market Cap: 63 million

New Dawn Reports $15.16 Million of Revenues and $0.01 EPS for the Quarter Ended June 30, 2012

New Dawn Mining Corp. (TSX: ND)

a junior gold company with an expanding base of assets and operations in Zimbabwe, announced that its financial results and corresponding Management's Discussion and Analysis for the quarter ended June 30, 2012 have now been filed on SEDAR (www.sedar.com) and are also available to view on the Company's web-site at www.newdawnmining.com.

$45.46 Million of Revenues and $0.06 EPS for 9 Months YTD

Highlights - Fiscal 3rd Quarter / 9 Months YTD - June 30, 2012

• $15.16 million in revenues ($45.46 million - 9 Months YTD)
• $0.58 million of net income allocable to common shareholders ($2.83 million - 9 Months YTD)
• $0.01 of EPS ($0.06 - 9 Months YTD)
• $0.83 million of EBITDA ($5.68 million - 9 months YTD)
• 9,536 ounces of gold produced (27,367 ounces - 9 Months YTD)
• Operating cash flows continue to be re-invested in Zimbabwe to fund expansion and development programs
• 8,000 meter exploration project at Camperdown Mine gold project continuing
• Contributions to Zimbabwe economy as described below

ABOUT NEW DAWN

New Dawn is a junior gold company currently focused on expanding its gold mining operations in Zimbabwe. New Dawn owns 100% of the Turk and Angelus Mine, the Old Nic Mine and the Camperdown Mine. In addition, New Dawn, through its Falgold subsidiary, owns approximately 85% of the Dalny Mine, the Golden Quarry Mine and the Venice Mine (currently not in operation), and a portfolio of prospective exploration acreage in Zimbabwe. These six mines, five of which are currently operational, are divided into three significant gold camps.

Last: 0.93Range: 1.40-0.69Market Cap 40 million

El Nino Ventures Inc. announces a 4.3% Zinc, 1.4% Lead and 54 g/t Silver over 81 Metres at the Murray Brook Polymetallic Deposit, Bathurst Mining Camp, New Brunswick

El Nino Ventures Inc. (TSX.V: ELN; OTCQX: ELNOF Frankfurt: E7Q)

is pleased to announce high grade assay results for an additional 9 holes from the latest round of drilling at the Murray Brook polymetallic massive sulfide deposit, Bathurst Mining Camp, New Brunswick. The drill program commenced February 9, 2012 and was completed June 17, 2012. Ninety seven vertical holes have been completed for a total of 18,470 metres drilled.

• Drilling highlights:
  • 4.27% zinc, 1.35% lead, 0.237 gpt gold and 54.0 gpt silver over 81.0 metres in MB‐2012‐124
    • Including 7.39% zinc, 2.55% lead, 0.278 gpt gold and 114.8 gpt silver over 10 metres
  • 3.65% zinc, 0.89% lead, 0.379 gpt gold and 38.5 gpt silver over 71.5 metres in MB‐2012‐126
    • Including 7.10% zinc, 2.13% lead, 0.441 gpt gold and 87.6 gpt silver over 11.5 metres
  • Metallurgical test work is in progress in advance of a Preliminary Economic Assessment

About El Nino Ventures Inc.



El Niño Ventures Inc. is an international exploration company, focused on exploring for lead, zinc, copper, gold and silver in New Brunswick, Canada and copper in the Democratic Republic of Congo ("DRC").

Last: 0.08Range: 0.18-0.07Market Cap: 4.7 million

Viking Systems Reports Second Quarter 2012 Results

Viking Systems, Inc. (OTCBB: VKNG), a leading worldwide developer, manufacturer and marketer of 3D and 2D visualization solutions for complex minimally invasive surgery today announced results for the quarter ended June 30, 2012.

Summary Financial Results for the Quarter

• Sales were $2.2 million for the second quarter of 2012, a decrease of 11% compared with the $2.5 million of sales reported for second quarter of 2011.

• Second quarter sales included revenue from sales of ten of Viking's 3DHD Vision Systems, including eight systems for clinical use outside the USA and two distributor demonstration systems.

• Gross profit for the quarter was $433,000 or 20% of sales, an increase of 13% compared with gross profit of $385,000 or 15% of sales reported for second quarter of 2011.

• The net loss for the quarter was $890,000 or $0.01 per share, compared with a net loss of $860,000 or $0.01 per share in the second quarter of 2011.

About Viking Systems, Inc.
Viking Systems, Inc. is a leading worldwide developer, manufacturer and marketer of 3D and 2D visualization solutions for complex minimally invasive surgery. It actively markets and sells the only stand alone, FDA cleared, cost-effective 3D system for use in minimally invasive laparoscopic surgery. Viking partners with medical device companies and healthcare facilities to provide surgeons with proprietary visualization systems enabling minimally invasive surgical procedures, which reduce patient trauma and recovery time.

Last Trade: 0.1895 52 Week: 0.32 – 0.1401 Market Cap: 13.75 Million

BioLife Solutions Announces 2012 Second Quarter Results: Eighth Straight Quarter of Record Revenue

BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced record results for the second quarter ended June 30, 2012.

Second Quarter Financial Results

Total revenue for the second quarter of 2012 was $1.1 million, compared to $623,000 in the same period of 2011. The increase of 76% from 2011 to 2012 was due primarily to higher sales to customers in the drug discovery and regenerative medicine market segments

Gross margin in the second quarter of 2012 was 41.5% compared to 53.6% in the second quarter of 2011.

For the second quarter of 2012, the Company reported a net loss of $499,000, or $(0.01) per share, compared with a net loss of $437,000, or $(0.01) per share, for the second quarter of 2011. Loss from operations in the second quarter of 2012 was $307,000, compared to the $260,000 loss from operations in the second quarter of 2011.

The Company ended the second quarter with $155,000 in cash. During the six months ended June 30, 2012, the Company reported cash provided by operations of $686,000. Included in this amount was an increase of $785,000 in deferred rent, which represents the amount the Company's landlord paid for certain tenant improvements related to the facility expansion.

About BioLife Solutions

BioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The Company's proprietary HypoThermosol® and CryoStor® platform of solutions are marketed to academic and commercial organizations involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced, delayed-onset cell damage and death. BioLife's enabling technology provides academic and clinical researchers significant improvements in post-thaw cell, tissue, and organ viability and function. For more information please visit www.biolifesolutions.com, and follow BioLife on Twitter.

Last Trade: 0.13 52 Week: 0.2199 – 0.02 Market Cap: 9.06 Million

Intelligent Systems Announces Second Quarter 2012 Results

Intelligent Systems Corporation (NYSE Amex:INS) (www.intelsys.com) announced today its financial results for the three and six month periods ended June 30, 2012.

For the three month period ended June 30, 2012, Intelligent Systems reported total revenue of $4,032,000, three percent lower than in the same quarter of 2011. The company reported a net loss of $265,000 ($0.03 per basic and diluted share) compared to net income of $637,000 ($0.07 per basic and diluted share) in the second quarter of 2011.

For the six month period ended June 30, 2012, total revenue was $8,126,000, six percent higher than revenue of $7,701,000 in the comparable period of 2011. Net loss in the six months ended June 30, 2012 was $521,000 ($0.06 per basic and diluted share) compared to net income of $283,000 ($0.03 basic and diluted share) in the comparable period in 2011.

About Intelligent Systems Corporation

For over thirty years, Intelligent Systems Corporation has identified, created, operated and grown early stage technology companies. The Company has operations and investments in the information technology and industrial products industries. The Company's principal majority-owned subsidiaries are CoreCard Software, Inc. (www.corecard.com), a provider of licensed software for managing accounts receivables, prepaid cards, private label revolving credit, debit and credit cards, fleet cards, consumer loans as well as processing services and ChemFree Corporation (www.chemfree.com), a leader in bioremediating parts washer equipment and supplies.

Last Trade: 1.5844 52 Week: 1.98 – 1.21 Market Cap: 14.19 Million

InVivo Therapeutics Reports Second Quarter 2012 Financial Results, Provides Business Update

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today reported the financial results for the three and six months ended June 30, 2012 and provided a business update.

Financial Results

For the three months ended June 30, 2012, the Company reported net income of $2,201,000 or $.03 per diluted share, compared to a net loss of $1,370,000, or $.03 per diluted share, for the three months ended June 30, 2011. Included in results for the three months ended June 30, 2012 and 2011 were non-cash derivative gains of $4,954,000, and $1,163,000, respectively, reflecting decreases in the fair value of the derivative warrant liability. Exclusive of the non-cash derivative gain, the pro forma net loss for the three months ended June 30, 2012, was $2,753,000, or $.04 per diluted share, compared to a pro forma net loss of $2,533,000, or $.05 per diluted share for 2011. Total operating expenses for the three months ended June 30, 2012 were $2,755,000 compared with $2,527,000 for the three months ended June 30, 2011. The Company ended the quarter with $18,037,000 of cash and cash equivalents.

For the six months ended June 30, 2012, the Company reported net income of $5,351,000 or $.07 per diluted share, compared to a net loss of $2,648,000, or $.05 per diluted share, for the six months ended June 30, 2011. Included in results for the six months ended June 30, 2012 and 2011 were non-cash derivative gains of $10,567,000, and $1,284,000, respectively, reflecting decreases in the fair value of the derivative warrant liability. Exclusive of the non-cash derivative gain, the pro forma net loss for the six months ended June 30, 2012, was $5,217,000, or $.09 per diluted share, compared to a pro forma net loss of $3,932,000, or $.08 per diluted share for 2011. Total operating expenses for the six months ended June 30, 2012 were $5,216,000 compared with $3,928,000 for the six months ended June 30, 2011.

About InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The Company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD., Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, M.D., who is affiliated with Massachusetts General Hospital. In 2011, data from a Company study was published in the Journal of Neuroscience Methods and won the prestigious 2011 Apple Award from the American Spinal Injury Association recognizing excellence in SCI research.

Last Trade: 2.46 52 Week: 3.23 - 0.60. Market Cap: 157.35 Million